cT1-2N0期乳腺癌腋窝淋巴结转移相关因素分析

doi:10.13481/j.1671-587x.20150627

Abstract

Abstract:

Objective To investigate the relationships between axillary lymph node metastasis and clinicopathologic features in the patients with cT_1-2N₀ breast cancer and clarify the law of axillary lymph node metastasis,and to find the risk factor,and provide the theoretical basis for individuation therapy. Methods 687 patients with cT_1-2N₀ breast cancer were divided into negative group and positive group according to the pathological results of axillary lymph node, and the clinicopathologic features were layered.The risk factors of axillary lymph node metastasis were screened out by Chi-square test and Logistic regression analysis. Results In 687 cases of cT_1-2N₀ breast cancer,156 (22.7%) cases were observed with axillary lymph node metastasis. The age,cT stage,pT stage,pathological type,vascular invasion,perineural invasion estrogen receptor(ER), progesterone receptor(PR),and molecular subtyping were the factors that influenced axillary lymph node metastasis in univariate analyses.The age<35 years,cT₂,invasive ductal carcinoma,vascular invasion positive and Luminal subtyping were the independent risk factors of axillary lymph nodes metastasis in multivariate analyses(r=3.440,P=0.010;r=1.770,P=0.007;r=3.397,P=0.001;r=7.434,P=0.000;r=2.212,P=0.015). Conclusion In the patients with cT_1-2N₀ breast cancer,the age, cT,pathological type, vascular invasion and molecular subtyping are important predictors of axillary lymph node metastasis and vascular invasion was the most important predictor.The preoperative comprehensive analysis and evaluation of clinical data and preoperative pathological results obtained will help to select the right surgical operation.

Key words: breast neoplasms, neoplasms staging, axillary lymph node metastasis, ultrasonic diagnosis, vascular invasion, Luminal subtyping

CLC Number:

R737.9

CUI Zhushan, DU Ye, ZHU Zhu, GAO Pin, LI Jiawei, FAN Zhimin. Analysis on related factors of axillary lymph node metastasis in patients with cT_1-2N₀ breast cancer[J].Journal of Jilin University Medicine Edition, 2015, 41(06): 1239-1244.

References

[1] Gentilini O, Veronesi U. Abandoning sentinel lymph node biopsy in early breast cancer? A new trial in progress at the European Institute of Oncology of Milan (SOUND: sentinel node vs observation after axillary ultrasound)[J].Breast, 2012, 21(5): 678-681.

[2] Giuliano AE, Hunt KK, Ballman KV, et al.Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial[J].AMA, 2011, 305(6): 569-575.

[3] Ojeda-Fournier H, Nguyen JQ.Ultrasound evaluation of regional breast lymph nodes [A]//Seminars in roentgenology[M].Seminars in roentgerology.WB Saunders, 2011, 46(1): 51-59.

[4] Misselt PN, Glazebrook KN, Reynolds C, et al.Predictive value of sonographic features of extranodal extension in axillary lymph nodes[J].Ultrasound Med, 2010, 29(12): 1705-1709.

[5] Ibrahim-Zada I, Grant CS, Glazebrook KN, et al.Preoperative axillary ultrasound in breast cancer: safely avoiding frozen section of sentinel lymph nodes in breast-conserving surgery[J].Am Coll Surgeons, 2013, 217(1): 7-15.

[6] Esen G, Gurses B, Yilmaz MH, et al.Gray scale and power Doppler US in the preoperative evaluation of axillary metastases in breast cancer patients with no palpable lymph nodes[J].Eur Radiol, 2005, 15(6): 1215-1223.

[7] Orucevic A, Reddy VB, Bloom KJ, et al.Predictors of lymph node metastasis in T1 breast carcinoma, stratified by patient age[J].Breast J, 2002, 8(6): 349-355.

[8] Estourgie SH, Nieweg OE, Olmos RAV, et al.Lymphatic drainage patterns from the breast[J].Ann Surg, 2004, 239(2): 232-237.

[9] Tseng HS, Chen LS, Kuo SJ, et al.Tumor characteristics of breast cancer in predicting axillary lymph node metastasis[J].Med Sci Monitor: Int Med J Exp d Clin Res, 2014, 20: 1155-1161.

[10] Li L, Chen LZ.Factors influencing axillary lymph node metastasis in invasive breast cancer[J].Asian Pac J Cancer Prev, 2012, 13(1): 251-254.

[11] Tan LGL, Tan YY, Heng D, et al.Predictors of axillary lymph node metastases in women with early breast cancer in Singapore[J].Singapore Med J, 2005, 46(12): 693-697.

[12] Xie F, Yang H, Wang S, et al.A logistic regression model for predicting axillary lymph node metastases in early breast carcinoma patients[J].Sensors, 2012, 12(7): 9936-9950.

[13] 俞理,胡滨,朱家安,等. 超声及其他多因素在乳腺癌腋窝淋巴结转移中的预测价值[J]. 中华临床医师杂志,2012,6(14) :3904-3908.

[14] Yin Y, Zeng K, Wu M, et al.The levels of Ki-67 positive are positively associated with lymph node metastasis in invasive ductal breast cancer[J].Cell Biochem Biophys, 2014, 70(2): 1145-1151.

[15] de Boer M, van Deurzen CHM, van Dijck JAAM, et al.Micrometastases or isolated tumor cells and the outcome of breast cancer[J].New Eng J Med, 2009, 361(7): 653-663.

[16] Jones T, Neboori H, Wu H, et al.Are breast cancer subtypes prognostic for nodal involvement and associated with clinicopathologic features at presentation in early-stage breast cancer?[J].Ann Surg Oncol, 2013, 20(9): 2866-2872.

[17] Crabb SJ, Cheang MCU, Leung S, et al.Basal breast cancer molecular subtype predicts for lower incidence of axillary lymph node metastases in primary breast cancer[J].Clin Breast Cancer, 2008, 8(3): 249-256.

[18] van Calster B, Bempt IV, Drijkoningen M, et al.Axillary lymph node status of operable breast cancers by combined steroid receptor and HER-2 status: triple positive tumours are more likely lymph node positive[J].Breast Cancer Res Treatment, 2009, 113(1): 181-187.

Analysis on related factors of axillary lymph node metastasis in patients with cT_1-2N₀ breast cancer

PDF (PC)

Like

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Metrics

Comments

Recommended 10

[1]	Xiuyan YU,Ting LI,Zhanjie CONG,Wenlong WANG,Xiaowei ZHANG,Xuefeng WU. Combined detection of hMAM, SBEM and CEACAM19 mRNA in peripheral blood of breast cancer patients and its clinical significance [J]. Journal of Jilin University(Medicine Edition), 2022, 48(1): 195-202.
[2]	Xiuyan YU,Chunying TIAN,Xiaowei ZHANG,Xuefeng WU. Clinical significances of serum levels of SBEM, hMAM and CEACAM19 in early diagnosis of breast cancer [J]. Journal of Jilin University(Medicine Edition), 2021, 47(6): 1518-1525.
[3]	Yang YU,Sainan LIU,Yunkai LIU,Yong LI,Yichun QIAO,Yi CHENG. Bioinformatic analysis on expression characteristics of PRPS2 and its relationship with prognosis of breast cancer [J]. Journal of Jilin University(Medicine Edition), 2021, 47(5): 1229-1236.
[4]	Qing WANG,Siqi XIE,Kai ZHENG,Yiyin TANG,Hongwan LI,Hengyu ZHANG,Mingjian TAN,Lei PENG,Dequan LIU,Shicong TANG. Detection of serum vitamin-B levels in breast cancer patients receiving different chemotherapy regimens and its clinical significance [J]. Journal of Jilin University(Medicine Edition), 2021, 47(3): 724-730.
[5]	Haoxuan TANG,Nanfeng MENG,Meiling DU,Wei WANG,Tao HE. Inhibitory effect of new VEGF monoclonal antibody combined with all-trans retinoic acid on proliferation of breast cancer MCF-7 cells [J]. Journal of Jilin University(Medicine Edition), 2021, 47(2): 344-351.
[6]	Dong CHEN,Haitao CHEN,Zhiyao LI,Fengming RANG,Xi ZHANG,Zhirui CHUAN,Shicong TANG,Xiaomao LUO. Effects of three-dimensional transrectal ultrasound and MRI in evaluation of extramural vascular invasion degrees of middle and lower rectal cancer [J]. Journal of Jilin University(Medicine Edition), 2021, 47(1): 203-209.
[7]	KONG Wencong, HE Wubin, SU Rongjian, JIA Daqi, GU Yanjiao, WANG Yue, DU Xiaoyuan. Inhibitory effect and apoptosisinduction of MST1R inhibitor BMS-777607 on proliferation of breast cancer MCF-7 cells [J]. Journal of Jilin University(Medicine Edition), 2020, 46(03): 451-457.
[8]	CHEN Zhouhua, GONG Hui, FENG Lei, XIAO Yujie, HUANG Lizhong. Induction of LPS on epithelial mesenchymal transition in breast cancer MDA-MB-231 cells and its effect on β-catenin expression [J]. Journal of Jilin University(Medicine Edition), 2020, 46(02): 309-315.
[9]	ZHOU Chun, WANG Guanghua, ZHANG Bangzhu. Effects of miR-367 on proliferation, invasion and migration of human breast cancer MCF-7 cells and their mechanisms [J]. Journal of Jilin University(Medicine Edition), 2019, 45(06): 1353-1360.
[10]	YANG Zhuangqing, LU Mei, YANG Xiaojuan, WANG Chang'an, ZOU Jieya. Inhibitory effect of inhibiting TRIM24 gene expression on proliferation, apopotosis,invasion and migration of breast cancer MCF-7 cells [J]. Journal of Jilin University(Medicine Edition), 2019, 45(06): 1379-1383.
[11]	YUE Yuan, XU Yinglian, WANG Jingjing, SUN Minying, ZHANG Zenan, ZHAO Xinyue, LI Zongpu, TAI Guixiang. Inhibitory effects of down-regulation of JNK enzymatic activity on growth of human prostate cancer cells, hepatocellular carcinoma cells and breast cancer cells [J]. Journal of Jilin University(Medicine Edition), 2019, 45(05): 1046-1051.
[12]	YU Xiuyan, WAN Guangcai, SUN Hongshuai, ZHU Hua, GAO Haiyan, WU Xuefeng. Relationship between fibrinogen and prognosis of breast cancer patients:A Meta-analysis [J]. Journal of Jilin University(Medicine Edition), 2019, 45(05): 1092-1097.
[13]	TAN Qi, REN Liqun, ZHANG Yibing, WANG Yadi, GU Zehui, HUANG Peng, CHEN Suxian. Application of bioinformatics in screening of miRNA biomarkers in triple-negative breast cancer [J]. Journal of Jilin University(Medicine Edition), 2019, 45(05): 1098-1105.
[14]	WANG Shuang, KANG Lihua, GUAN Meng, WANG Lei, LI Beibei, ZHAO Yue, SONG Yanqiu, YANG Tingting. Clinical application of apatinib mesylate combined with chemotherapy in treatment of patients with advanced breast cancer [J]. Journal of Jilin University(Medicine Edition), 2019, 45(05): 1152-1158.
[15]	XIN Rui, LI Dong, XU Huiying, WANG Chunyu, QU Danhua, SUN Haifeng. Influence of miRNA-21 in radiosensitivity of breast cancer cells and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2019, 45(04): 772-778.

Analysis on related factors of axillary lymph node metastasis in patients with cT1-2N0 breast cancer

PDF (PC)

Like

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Metrics

Comments

Recommended 10

Analysis on related factors of axillary lymph node metastasis in patients with cT_1-2N₀ breast cancer